세계의 심상성 여드름 시장 보고서(2025년)

Acne Vulgaris Global Market Report 2025

US $ 4,490 ￦ 6,242,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,023,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,803,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

심상성 여드름 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안의 예상 성장은 스킨케어 인식 증가, 10대 인구 증가, 자기 관리 및 웰빙에 대한 관심 증가, 성인 여드름 발생률 증가, 원격 의료 및 전자상거래의 확대에 기인할 수 있습니다.

스킨 케어 제품에 대한 수요 증가가 심상성 여드름 시장의 성장을 이끌 것으로 예측됩니다. 스킨케어 제품은 클렌징, 보습, 보호 기능을 통해 다양한 피부 고민을 해결하고 피부 건강과 외모를 개선하도록 고안된 제품입니다. 이러한 수요 증가는 소셜 미디어, 피부과적 고민의 증가, 제품 혁신, 예방적 스킨케어로의 전환 등의 영향을 받고 있습니다. 심상성 여드름 치료에는 과잉 피지 분비, 모공 막힘, 세균 번식 등 증상의 근본 원인을 타겟으로 한 스킨 케어 제품이 유효합니다. 과산화 벤조일, 레티노이드 등의 성분은 피부의 각질을 제거하고, 염증을 억제하며, 투명감 있는 건강한 피부를 촉진합니다. 예를 들어 2024년 8월 Toiletry and Perfumery Association(CTPA)은 유럽 화장품 시장의 소매 판매 가격(RSP) 평가액이 2022년 880억 유로(약 930억 달러)에서 2023년에는 960억 유로(약 1,050억 달러)에 달했다고 보고했습니다. 이것은 스킨 케어에 대한 의식의 고조와 심상성 여드름 시장을 견인하는 역할을 부각하고 있습니다.

심상성 여드름 시장의 주요 기업은 트리플 콤비네이션 외용 치료와 같은 혁신적인 솔루션의 개발에 주력하고 있으며, 여드름을 관리하기 위한 간소화된 1일 1회의 도포를 제공합니다. 약은 여드름과 건선과 같은 피부 질환의 치료 효과를 높이기 위해 각각이 증상의 다른 측면을 다루는 3가지 활성 성분을 통합한 것입니다. 예를 들어, 2023년 10월 캐나다에 본사를 둔 제약 회사인 Bausch Health Companies Inc.는 클린다마이신 인산염, 아다팔렌, 과산화벤조일이 함유된 국소용 젤인 Cabtreo에 대해 미국 식품의약국(FDA)의 승인을 받았습니다. 항생제, 레티노이드, 항균제를 배합하여 여드름 흔적을 효과적으로 치료하고 미래의 분출물을 예방합니다. 간단한 도포 방법과 양호한 안전성 프로파일로 폭넓은 환자에게 있어 실행 가능한 치료 옵션이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 심상성 여드름 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 심상성 여드름 시장 : 성장률 분석
• 세계의 심상성 여드름 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 심상성 여드름 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 심상성 여드름 전체 시장(TAM)

제6장 시장 세분화

• 세계의 심상성 여드름 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 전신 요법
• 호르몬 요법
• 물리 치료
• 국소 병용 요법
• 기타 유형
• 세계의 심상성 여드름 시장 : 연령층별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 10-17세
• 18-44세
• 45-64세
• 65세 이상
• 세계의 심상성 여드름 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 온라인 약국
• 세계의 심상성 여드름 시장 : 전신 요법 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 경구 항생제
• 경구 레티노이드
• 경구 항염증제
• 세계의 심상성 여드름 시장 : 호르몬 요법 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 경구 피임약
• 안드로겐 수용체 억제제
• 세계의 심상성 여드름 시장 : 물리 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 레이저 치료
• 광선 치료
• 화학적 박피
• 미세 박피술
• 세계의 심상성 여드름 시장 : 국소 병용 요법 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 레티노이드와 항생제 조합
• 과산화벤조일과 항생제 조합
• 레티노이드와 과산화벤조일 조합
• 세계의 심상성 여드름 시장 : 기타 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 허브 및 자연 요법
• 생물학적 치료
• 새로운 요법

제7장 지역별/국가별 분석

• 세계의 심상성 여드름 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 심상성 여드름 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 심상성 여드름 시장 : 경쟁 구도
• 심상성 여드름 시장 : 기업 프로파일
  • Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Johnson and Johnson 개요, 제품 및 서비스, 전략 및 재무 분석
  • AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • L'Oreal Paris 개요, 제품 및 서비스, 전략 및 재무 분석
  • GlaxoSmithKline Plc. 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Reckitt Benckiser Group plc
• Viatris Inc.
• Teva Pharmaceuticals
• Bausch Healh Companies
• Sun Pharmaceutical Industries Ltd.
• Incyte
• Aurobindo Pharma
• Lupin Ltd.
• Torrent Pharmaceuticals
• Biocon
• Stiefel Laboratories
• Mayne Pharma Group Limited
• Paratek Pharmaceuticals
• Cosmo Pharmaceuticals
• AOBiome

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 심상성 여드름 시장(2029년) : 새로운 기회를 제공하는 국가
• 심상성 여드름 시장(2029년) : 새로운 기회를 제공하는 부문
• 심상성 여드름 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

KTH

영문 목차

영문목차

Acne vulgaris is a prevalent chronic inflammatory skin disorder that primarily affects the pilosebaceous units. It is characterized by the development of comedones, papules, pustules, nodules, and cysts, often triggered by factors such as excessive sebum production, follicular hyperkeratinization, Cutibacterium acnes proliferation, and inflammation. This condition typically appears on the face, chest, and back, varying in severity and carrying the risk of scarring.

The primary treatment types for acne vulgaris include systemic therapy, hormonal therapy, physical treatments, topical combination therapy, and others. Systemic therapy involves delivering medication through the bloodstream to treat the entire body and is commonly used for conditions such as cancer, autoimmune disorders, and infections. Treatments are categorized based on age groups, including 10 to 17 years, 18 to 44 years, 45 to 64 years, and 65 years and older. These treatments are distributed through various channels, including hospital pharmacies and online pharmacies.

The acne vulgaris market research report is one of a series of new reports from The Business Research Company that provides acne vulgaris market statistics, including acne vulgaris industry global market size, regional shares, competitors with an acne vulgaris market share, detailed acne vulgaris market segments, market trends and opportunities, and any further data you may need to thrive in the acne vulgaris industry. This acne vulgaris market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acne vulgaris market size has grown strongly in recent years. It will grow from $7.94 billion in 2024 to $8.47 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to the increasing prevalence of acne, a growing consumer preference for natural ingredients, the expansion of online retail channels, heightened investment in research and development, and the wider availability of over-the-counter products.

The acne vulgaris market size is expected to see strong growth in the next few years. It will grow to $10.89 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The projected growth in the forecast period can be attributed to increasing skincare awareness, a rising teenage population, a growing focus on self-care and wellness, a higher incidence of adult acne, and the expansion of telemedicine and e-commerce. Key trends during this period include technological advancements, the introduction of advanced drugs, innovative product development, increased clinical approvals, and breakthroughs in novel medical processes.

The rising demand for skincare products is expected to drive the growth of the acne vulgaris market. Skincare products are formulations designed to improve skin health and appearance, addressing various skin concerns through cleansing, moisturizing, and protection. This increasing demand is influenced by social media, growing dermatological concerns, product innovations, and a shift toward preventive skincare. Acne vulgaris treatments benefit from skincare products that target the root causes of the condition, such as excess sebum production, clogged pores, and bacterial growth. Ingredients such as salicylic acid, benzoyl peroxide, and retinoids help exfoliate the skin, reduce inflammation, and promote clearer, healthier skin. For example, in August 2024, The Cosmetic, Toiletry and Perfumery Association (CTPA), a UK-based non-profit organization, reported that the European cosmetics market reached a retail sales price (RSP) valuation of €96 billion (approximately $105 billion) in 2023, up from €88 billion (approximately $93 billion) in 2022. This highlights the increasing awareness of skincare and its role in driving the acne vulgaris market.

Leading companies in the acne vulgaris market are focusing on developing innovative solutions such as triple-combination topical treatments to offer a simplified, once-daily application for managing acne. A triple-combination topical treatment integrates three active ingredients, each addressing different aspects of a condition to enhance therapeutic effects in treating skin disorders such as acne and psoriasis. For instance, in October 2023, Bausch Health Companies Inc., a Canada-based pharmaceutical company, received approval from the Food and Drug Administration (FDA) for Cabtreo, a topical gel containing clindamycin phosphate, adapalene, and benzoyl peroxide. This formulation is designed for patients aged 12 years and older to treat acne vulgaris. By combining an antibiotic, a retinoid, and an antibacterial agent, Cabtreo effectively targets acne lesions and helps prevent future breakouts. Its convenient application method and favorable safety profile make it a viable treatment option for a broad range of patients.

In September 2023, Glenmark Specialty SA, an India-based pharmaceutical company, announced a collaboration with Cosmo Pharmaceuticals to expand its dermatology portfolio and meet the growing demand for acne treatments. This partnership aims to increase the availability of Winlevi (clascoterone cream 1%) across 15 EU countries, South Africa, and the UK, ensuring broader access to innovative acne solutions. Cosmo Pharmaceuticals NV, an Ireland-based pharmaceutical company, specializes in topical treatments for acne vulgaris.

Major players in the acne vulgaris market are Pfizer Inc., Johnson and Johnson, AbbVie Inc., L'Oreal Paris, GlaxoSmithKline Plc., Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals, Bausch Healh Companies, Sun Pharmaceutical Industries Ltd., Incyte, Aurobindo Pharma, Lupin Ltd., Torrent Pharmaceuticals, Biocon, Stiefel Laboratories, Mayne Pharma Group Limited, Paratek Pharmaceuticals, Cosmo Pharmaceuticals, AOBiome.

North America was the largest region in the acne vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acne vulgaris report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acne vulgaris market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acne vulgaris market consists of sales of topical retinoids, oral retinoids, benzoyl peroxide formulations, oral antibiotics, hormonal therapies, and salicylic acid-based treatments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acne Vulgaris Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acne vulgaris market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acne vulgaris ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acne vulgaris market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Systemic Therapy; Hormonal Therapy; Physical Treatment; Topical Combination Therapy; Other Types
• 2) By Age Group: 10 To 17 Years; 18 To 44 Years; 45 To 64 Years; 65 Years And Above
• 3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Systemic Therapy: Oral Antibiotics; Oral Retinoids; Oral Anti-Inflammatory Agents
• 2) By Hormonal Therapy: Oral Contraceptives; Androgen Receptor Inhibitors
• 3) By Physical Treatment: Laser Therapy; Light-Based Therapy; Chemical Peels; Microdermabrasion
• 4) By Topical Combination Therapy: Retinoid And Antibiotic Combinations; Benzoyl Peroxide And Antibiotic Combinations; Retinoid And Benzoyl Peroxide Combinations
• 5) By Other Types: Herbal And Natural Remedies; Biologic Therapies; Emerging Therapies
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson; AbbVie Inc.; L'Oreal Paris; GlaxoSmithKline Plc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acne Vulgaris Market Characteristics

3. Acne Vulgaris Market Trends And Strategies

4. Acne Vulgaris Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Acne Vulgaris Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acne Vulgaris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acne Vulgaris Market Growth Rate Analysis
• 5.4. Global Acne Vulgaris Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acne Vulgaris Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acne Vulgaris Total Addressable Market (TAM)

6. Acne Vulgaris Market Segmentation

• 6.1. Global Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systemic Therapy
• Hormonal Therapy
• Physical Treatment
• Topical Combination Therapy
• Other Types
• 6.2. Global Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10 To 17 Years
• 18 To 44 Years
• 45 To 64 Years
• 65 Years And Aove
• 6.3. Global Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Online Pharmacies
• 6.4. Global Acne Vulgaris Market, Sub-Segmentation Of Systemic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Antibiotics
• Oral Retinoids
• Oral Anti-Inflammatory Agents
• 6.5. Global Acne Vulgaris Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Contraceptives
• Androgen Receptor Inhibitors
• 6.6. Global Acne Vulgaris Market, Sub-Segmentation Of Physical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laser Therapy
• Light-Based Therapy
• Chemical Peels
• Microdermabrasion
• 6.7. Global Acne Vulgaris Market, Sub-Segmentation Of Topical Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retinoid And Antibiotic Combinations
• Benzoyl Peroxide And Antibiotic Combinations
• Retinoid And Benzoyl Peroxide Combinations
• 6.8. Global Acne Vulgaris Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal And Natural Remedies
• Biologic Therapies
• Emerging Therapies

7. Acne Vulgaris Market Regional And Country Analysis

• 7.1. Global Acne Vulgaris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acne Vulgaris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acne Vulgaris Market

• 8.1. Asia-Pacific Acne Vulgaris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acne Vulgaris Market

• 9.1. China Acne Vulgaris Market Overview
• 9.2. China Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acne Vulgaris Market

• 10.1. India Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acne Vulgaris Market

• 11.1. Japan Acne Vulgaris Market Overview
• 11.2. Japan Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acne Vulgaris Market

• 12.1. Australia Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acne Vulgaris Market

• 13.1. Indonesia Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acne Vulgaris Market

• 14.1. South Korea Acne Vulgaris Market Overview
• 14.2. South Korea Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acne Vulgaris Market

• 15.1. Western Europe Acne Vulgaris Market Overview
• 15.2. Western Europe Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acne Vulgaris Market

• 16.1. UK Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acne Vulgaris Market

• 17.1. Germany Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acne Vulgaris Market

• 18.1. France Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acne Vulgaris Market

• 19.1. Italy Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acne Vulgaris Market

• 20.1. Spain Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acne Vulgaris Market

• 21.1. Eastern Europe Acne Vulgaris Market Overview
• 21.2. Eastern Europe Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acne Vulgaris Market

• 22.1. Russia Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acne Vulgaris Market

• 23.1. North America Acne Vulgaris Market Overview
• 23.2. North America Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acne Vulgaris Market

• 24.1. USA Acne Vulgaris Market Overview
• 24.2. USA Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acne Vulgaris Market

• 25.1. Canada Acne Vulgaris Market Overview
• 25.2. Canada Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acne Vulgaris Market

• 26.1. South America Acne Vulgaris Market Overview
• 26.2. South America Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acne Vulgaris Market

• 27.1. Brazil Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acne Vulgaris Market

• 28.1. Middle East Acne Vulgaris Market Overview
• 28.2. Middle East Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acne Vulgaris Market

• 29.1. Africa Acne Vulgaris Market Overview
• 29.2. Africa Acne Vulgaris Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acne Vulgaris Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acne Vulgaris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acne Vulgaris Market Competitive Landscape And Company Profiles

• 30.1. Acne Vulgaris Market Competitive Landscape
• 30.2. Acne Vulgaris Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. L'Oreal Paris Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline Plc. Overview, Products and Services, Strategy and Financial Analysis

31. Acne Vulgaris Market Other Major And Innovative Companies

• 31.1. Reckitt Benckiser Group plc
• 31.2. Viatris Inc.
• 31.3. Teva Pharmaceuticals
• 31.4. Bausch Healh Companies
• 31.5. Sun Pharmaceutical Industries Ltd.
• 31.6. Incyte
• 31.7. Aurobindo Pharma
• 31.8. Lupin Ltd.
• 31.9. Torrent Pharmaceuticals
• 31.10. Biocon
• 31.11. Stiefel Laboratories
• 31.12. Mayne Pharma Group Limited
• 31.13. Paratek Pharmaceuticals
• 31.14. Cosmo Pharmaceuticals
• 31.15. AOBiome

32. Global Acne Vulgaris Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acne Vulgaris Market

34. Recent Developments In The Acne Vulgaris Market

35. Acne Vulgaris Market High Potential Countries, Segments and Strategies

• 35.1 Acne Vulgaris Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acne Vulgaris Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acne Vulgaris Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료